KRAS and pancreatic neoplasm: To understand how the immunological milieu at distant organ sites is affected by the presence of primary pancreatic tumors, we used a well-established Kras-driven model of spontaneous pancreatic tumorigenesis, LSL-KrasG12D/+; p48Cre/+ (KC), which is not proficient at driving metastasis2.